SARS-CoV-2 Vaccines and the Skin

Galván Casas, Cristina; Català, A.; Muñoz Santos, Carlos

dc.contributor	Hospital General de Granollers
dc.contributor.author	Galván Casas, Cristina
dc.contributor.author	Català, A.
dc.contributor.author	Muñoz Santos, Carlos
dc.date.accessioned	2022-03-18T08:56:47Z
dc.date.available	2022-03-18T08:56:47Z
dc.date.issued	2021-10-01
dc.identifier.citation	Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr. 2021 Oct;112(9):828-836.
dc.identifier.issn	0001-7310
dc.identifier.uri	https://hdl.handle.net/11351/7206
dc.description	Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Skin reactions; Vacines
dc.description.abstract	Vaccines against the severe acute respiratory coronavirus 2, which are the first to be used in humans against any coronavirus, were developed and produced in record time. Dermatologic adverse effects appeared during clinical trials and have also been described in the population since approval. Just as descriptions and categorization of skin manifestations of the coronavirus disease 2019 proved important for understanding the disease itself, characterizing the effects of vaccines may also further that goal. This paper reviews the properties of the different types of vaccines currently available and under development and describes how they interact with the immune system and the clinical signs they may cause. We focus on dermatologic adverse effects reported to date and recommendations for managing them.
dc.language.iso	eng
dc.publisher	Elsevier España
dc.relation.ispartofseries	Actas dermo-sifiliográficas;112(9)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	COVID-19 (Malaltia)
dc.subject	Vacunes
dc.subject	Pell - Malalties
dc.subject.mesh	Vaccines
dc.subject.mesh	Skin Manifestations
dc.subject.mesh	Coronavirus Infections
dc.title	SARS-CoV-2 Vaccines and the Skin
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.adengl.2021.07.028
dc.subject.decs	vacunas
dc.subject.decs	manifestaciones cutáneas
dc.subject.decs	infecciones por Coronavirus
dc.relation.publishversion	https://doi.org/10.1016/j.adengl.2021.07.028
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.authoraffiliation	[Galván-Casas C] Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain. [Català A] Servicio de Dermatología, Sede Plató, Hospital Clínic, Barcelona, Spain. [Muñoz-Santos C] Servicio de Dermatología, Hospital General de Granollers, Granollers, Spain
dc.identifier.pmid	34483343
dc.rights.accessrights	info:eu-repo/semantics/openAccess